3-dimethylaminobenzyl chloride hydrochloride | 117347-85-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-dimethylaminobenzyl chloride hydrochloride
• 英文别名: 3-(chloromethyl)-N,N-dimethylaniline hydrochloride；m-dimethylaminobenzyl chloride hydrochloride；3-(chloromethyl)-N,N-dimethylaniline;hydrochloride
• CAS: 117347-85-0
• 化学式: C₉H₁₂ClN*ClH
• mdl: MFCD12031761
• 分子量: 206.115
• InChiKey: LLVZIOLOBGBRGF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.67
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  3.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  3-dimethylaminobenzyl chloride hydrochloride 在 盐酸 、 sodium hydroxide 作用下， 以 乙醇 为溶剂， 反应 9.0h， 生成 6-(3-Dimethylamino-benzylsulfanyl)-2-phenyl-imidazo[1,2-b]pyridazin-3-ol
  参考文献：
  名称：

  Barlin, Gordon B.; Davies, Les P.; Ireland, Stephen J., Australian Journal of Chemistry, 1989, vol. 42, # 7, p. 1133 - 1146

  摘要：

  DOI：
• 作为产物：
  描述：

  间二甲氨基苯甲酸 在 盐酸 、 lithium aluminium tetrahydride 、 硫酸 、 sodium carbonate 作用下， 反应 19.5h， 生成 3-dimethylaminobenzyl chloride hydrochloride
  参考文献：
  名称：

  Barlin, Gordon B.; Davies, Les P.; Ireland, Stephen J., Australian Journal of Chemistry, 1989, vol. 42, # 7, p. 1133 - 1146

  摘要：

  DOI：

文献信息

• Pyridyl-substituted imidazoles, compositions containing same and methods
  申请人：Tanabe Seiyaku Company, Ltd.

  公开号：US04996217A1

  公开（公告）日：1991-02-26

  Novel imidazole of the formula: ##STR1## wherein Ring A is pyridyl group or a substituted pyridyl group; Ring B is phenyl group or a substituted phenyl group; R.sup.1 and R.sup.2 are hydrogen atom or are combined together to form a group of the formula: --(CH.sub.2).sub.q --; m is 1 or 2; n is 0, 1 or 2; and q is 3 or 4, or a salt thereof are disclosed. Said derivative (I) and a salt thereof are useful as anti-ulcer agents.

  式（I）所示的新咪唑化合物：##STR1##其中，环A为吡啶基或取代的吡啶基；环B为苯基或取代的苯基；R1和R2为氢原子或结合在一起形成式--（CH2）q--的基团；m为1或2；n为0、1或2；q为3或4，或其盐被公开。所述衍生物（I）及其盐可作为抗溃疡剂使用。
• Synthesis of Arylethylamines <i>via</i> C(sp³)–C(sp³) Palladium-Catalyzed Cross-Coupling
  作者：Rhys A. Lippa、David J. Battersby、John A. Murphy、Tim N. Barrett

  DOI：10.1021/acs.joc.0c02958

  日期：2021.2.19

  pharmaceutical, and agrochemical compounds. Access to such scaffolds has been the subject of long-standing synthetic interest. Herein, we report the synthesis of such scaffolds via a palladium-catalyzed C(sp3)–C(sp3) coupling between (chloromethyl)aryls and air-/moisture-stable N,N-dialkylaminomethyltrifluoroborate salts. Rapid hit identification was achieved using microscale high-throughput experimentation

  取代的芳基乙胺代表天然，药物和农业化学化合物中的关键结构基序。长期以来，使用这种支架一直是人们关注的主题。在这里，我们报告了通过（氯甲基）芳基与空气/水分稳定的N，N之间的钯催化的C（sp 3）–C（sp 3）偶联而合成此类支架的方法-二烷基氨基甲基三氟硼酸盐。使用微型高通量实验可实现快速命中鉴定，然后进行毫摩尔规模的反应参数优化。获得了各种结构和电子形式的芳基乙胺产品，收率中等至优异（27–96％，> 60个示例）。提出该反应机理是通过在氧化加成之前形成三烷基苄基铵物质而进行的。
• Imidazole derivative, pharmaceutically acceptable salt thereof, and
  申请人：Arax Co., Ltd.

  公开号：US05733922A1

  公开（公告）日：1998-03-31

  An imidazole derivative represented by one of formulas (1), wherein R.sub.1, R.sub.2 represents hydrogen atom, lower alkyl, aryl, aralkyl group, or R.sub.1 and R.sub.2 cooperate to represent alkylene, alkylidene, arylalkylidene group, R.sub.3 representing hydrogen atom, lower alkyl or alkanoyl group, or aralkyl or arylcarbonyl group, wherein at least one of A and B represents a group represented by formula (2), wherein m represents an integer 1-4, R.sub.4 representing nitrogen-containing aromatic ring that may be substituted by lower alkyl, alkoxy or alkanoyl group, or phenyl group represented by formula (3), R.sub.5, R.sub.6 representing hydrogen atom, lower alkyl or alkenyl group, or lower alkanoyl or arylcarbonyl group which may be substituted by a halogen atom, R.sub.7 representing hydrogen or halogen atom, hydroxyl or nitro group, or lower alkyl or alkoxy group, wherein the other of A and B represents oxygen or sulfur atom, hydroxyl, mercapto, alkylthio, alkenylthio or aralkylthio group, or group represented by the formula (2), ##STR1##

  一个由以下公式之一表示的咪唑衍生物，其中R.sub.1，R.sub.2代表氢原子，较低的烷基，芳基，芳基烷基，或R.sub.1和R.sub.2合作表示烷基，烷基亚基，芳基烷基亚基，R.sub.3代表氢原子，较低的烷基或烷酰基，或芳基烷基或芳基羰基，其中A和B中的至少一个表示由公式（2）表示的基团，其中m代表整数1-4，R.sub.4代表可能被较低的烷基，烷氧基或烷酰基取代的含氮芳环，或由公式（3）表示的苯基，R.sub.5，R.sub.6代表氢原子，较低的烷基或烯基基团，或可能被卤原子取代的较低的烷酰基或芳基羰基，R.sub.7代表氢或卤原子，羟基或硝基基团，或较低的烷基或烷氧基，其中A和B中的另一个代表氧或硫原子，羟基，巯基，烷硫基，烯基硫基或芳基硫基，或由以下公式表示的基团： ##STR1##
• Imidazole derivatives, processes for the preparation of the same, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments of therapeutic value, and intermediates formed during said processes
  申请人：TANABE SEIYAKU CO., LTD.

  公开号：EP0270091A1

  公开（公告）日：1988-06-08

  Novel imidazole of the formula: wherein Ring A is pyridyl group or a substituted pyridyl group; Ring B is phenyl group or a substituted phenyl group; R1 and R2 are hydrogen atom or are combined together to form a group of the formula: --(CH2 )q-; m is 1 or 2; n is 0, 1 or 2; and q is 3 or 4, or a salt thereof are disclosed. Said derivative (I) and a salt thereof are useful an anti-ulcer agents. Processes for the preparation of such derivatives are also provided, together with chemical intermediates formed during said processes. Pharmaceutical compositions comprising the same are further provided. The use of such compounds is also provided for the manufacture of medicaments of therapeutic value.

  本发明公开了式如下的新型咪唑：其中环 A 是吡啶基或取代的吡啶基；环 B 是苯基或取代的苯基；R1 和 R2 是氢原子或结合在一起形成式如下的基团：--(CH2 )q-；m 是 1 或 2；n 是 0、1 或 2；q 是 3 或 4，或其盐。 上述衍生物 (I) 及其盐可用于抗溃疡剂。 本发明还提供了制备此类衍生物的工艺，以及在上述工艺中形成的化学中间体。 本发明还提供了包含上述衍生物的药物组合物。 本发明还提供了此类化合物在制造具有治疗价值的药物中的用途。
• Imidazole derivative, pharmaceutically acceptable salt thereof, process of manufacture therefor, and anti-ulcer drug including such derivative or salt
  申请人：ARAX CO., LTD.

  公开号：EP0728747A1

  公开（公告）日：1996-08-28

  An imidazole derivative represented by one of formulas (1), wherein R1, R2 represents hydrogen atom, lower alkyl, aryl, aralkyl group, or R1 and R2 cooperate to represent alkylene, alkylidene, arylalkylidene group, R3 representing hydrogen atom, lower alkyl or alkanoyl group, or aralkyl or arylcarbonyl group, wherein at least one of A and B represents a group represented by formula (2), wherein m represents an integer 1-4, R4 representing nitrogen-containing aromatic ring that may be substituted by lower alkyl, alkoxy or alkanoyl group, or phenyl group represented by formula (3), R5, R6 representing hydrogen atom, lower alkyl or alkenyl group, or lower alkanoyl or arylcarbonyl group which may be substituted by a halogen atom, R7 representing hydrogen or halogen atom, hydroxyl or nitro group, or lower alkyl or alkoxy group, wherein the other of A and B represents oxygen or sulfur atom, hydroxyl, mercapto, alkylthio, alkenylthio or aralkylthio group, or group represented by the formula (2),         (2)   -S-(CH2)m-R4

  由式(1)之一代表的咪唑衍生物，其中 R1、R2 代表氢原子、低级烷基、芳基、芳烷基，或 R1 和 R2 配合代表亚烷基、亚烷基、亚芳烷基，R3 代表氢原子、低级烷基或烷酰基，或芳烷基或芳羰基，其中 A 和 B 中至少有一个代表由式(2)代表的基团，其中 m 代表整数 1-4，R4 代表可被低级烷基取代的含氮芳环、R5、R6 代表氢原子、低级烷基或烯基、或可被卤素原子取代的低级烷酰基或芳基羰基，R7 代表氢或卤素原子、羟基或硝基、或低级烷基或烷氧基，其中 A 和 B 中的另一个代表氧或硫原子、羟基、巯基、烷硫基、烯硫基或芳硫基或式（2）所代表的基团、 (2) -S-(CH2)m-R4